H.R. 2410 · 115th Congress

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

Stage
Passed a chamber
Sponsor
Danny Davis
Introduced
2017-05-11
Latest action
2018-02-27 · Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Action history

  1. 2018-02-27Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. 2018-02-26Motion to reconsider laid on the table Agreed to without objection.
  3. 2018-02-26On motion to suspend the rules and pass the bill Agreed to by voice vote.
  4. 2018-02-26DEBATE - The House proceeded with forty minutes of debate on H.R. 2410.
  5. 2018-02-26Considered under suspension of the rules.
  6. 2018-02-26Mr. Burgess moved to suspend the rules and pass the bill.
  7. 2017-10-19Reported by the Committee on Energy and Commerce. H. Rept. 115-354.
  8. 2017-10-19Placed on the Union Calendar, Calendar No. 258.
  9. 2017-06-07Committee Consideration and Mark-up Session Held.
  10. 2017-06-07Ordered to be Reported by Voice Vote.
  11. 2017-05-18Subcommittee Consideration and Mark-up Session Held.
  12. 2017-05-18Forwarded by Subcommittee to Full Committee by Voice Vote .
  13. 2017-05-12Referred to the Subcommittee on Health.
  14. 2017-05-11Introduced in House
  15. 2017-05-11Referred to the House Committee on Energy and Commerce.